Breaking News on Global Pharmaceutical Technology & Manufacturing

Report abuse about a comment

Project should include participation by supply chain partners

Counterfeiting is a priority across the phamaceutical supply chain. Serialization and Pedigree requirements and solutions are still evolving. I would like to see participation in these types of projects by Manufacturers, Distributors, Retailers and Consumers. Also, the many standards determining bodies, i.e, GS1, HDMA, etc. should be connected to the effort. There needs to be a holistic approach that ties together the many requirements and regulations into one universal solution with defined standards. Many supply chain partners are looking to 2015 and the California mandate. This effort should be synergistic with state and federal regulations.

Posted by Bill Ricigliano
14 October 2010 | 14h31

Please fill in the box below to tell us why you feel the post breaks our rules. When you are finished, click on "Send" so that it can be reviewed by a moderator.

Your name *
Your email *

We will not publish your email on the site

Reason *

Back to: FDA & WHO collaborate on surveillance of counterfeit drugs

Key Industry Events


Access all events listing

Our events, Shows & Conferences...